Home/Filings/4/0001209191-17-002130
4//SEC Filing

Minerva Neurosciences, Inc. 4

Accession 0001209191-17-002130

$NERVCIK 0001598646operating

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:39 PM ET

Size

5.6 KB

Accession

0001209191-17-002130

Insider Transaction Report

Form 4
Period: 2017-01-03
Davidson Michael
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-01-03+145,000145,000 total
    Exercise: $11.75Exp: 2027-01-02Common Stock (145,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the option shall vest and become exercisable as to 25% on January 3, 2018; the balance of the shares underlying the option shall vest and become exercisable in 12 successive equal quarterly installments, in each case so long as the Reporting Person provides continuous service to the Issuer on each such date.

Issuer

Minerva Neurosciences, Inc.

CIK 0001598646

Entity typeoperating
IncorporatedMA

Related Parties

1
  • filerCIK 0001598646

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:39 PM ET
Size
5.6 KB